Literature DB >> 1336460

Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions.

S Mangani1, K Håkansson.   

Abstract

The structures of human carbonic-anhydrase-II complexes with the anionic inhibitors hydrogen sulphide (HS-) and nitrate (NO3-) have been determined by X-ray diffraction at 0.19-nm resolution from crystals soaked at pH 7.8 and 6.0, respectively. The modes of binding of these two anions differ markedly from each other. The strong inhibitor HS- replaces the native zinc-bound water/hydroxide (Wat263) leaving the tetrahedral metal geometry unaltered and acts as a hydrogen-bonding donor towards Thr199 gamma. The weak NO3- inhibitor does not displace Wat263 from the metal coordination but occupies a fifth binding site changing the zinc coordination polyhedron into a slightly distorted trigonal bipyramid. The interaction of NO3- with the metal is weak; the nearest of its oxygen atoms being at a distance of 0.28 nm from the zinc ion. The binding of nitrate to the enzyme is completed by a hydrogen bond to the metal coordinated Wat263 and a second one to a water molecule of the active-site cavity. The structures of the two complexes help to rationalize the binding of anionic inhibitors to carbonic anhydrase and the binding mode displayed by NO39 may be relevant to the catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336460     DOI: 10.1111/j.1432-1033.1992.tb17490.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

Review 1.  Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.

Authors:  Vijay M Krishnamurthy; George K Kaufman; Adam R Urbach; Irina Gitlin; Katherine L Gudiksen; Douglas B Weibel; George M Whitesides
Journal:  Chem Rev       Date:  2008-03       Impact factor: 60.622

2.  Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules.

Authors:  L C Pedersen; V C Yee; P D Bishop; I Le Trong; D C Teller; R E Stenkamp
Journal:  Protein Sci       Date:  1994-07       Impact factor: 6.725

3.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

Authors:  V C Yee; L C Pedersen; I Le Trong; P D Bishop; R E Stenkamp; D C Teller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

4.  A plant-type (beta-class) carbonic anhydrase in the thermophilic methanoarchaeon Methanobacterium thermoautotrophicum.

Authors:  K S Smith; J G Ferry
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

5.  Insights towards sulfonamide drug specificity in α-carbonic anhydrases.

Authors:  Mayank Aggarwal; Bhargav Kondeti; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2012-08-28       Impact factor: 3.641

Review 6.  Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors.

Authors:  Melissa A Pinard; Brian Mahon; Robert McKenna
Journal:  Biomed Res Int       Date:  2015-02-24       Impact factor: 3.411

7.  Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  BMC Biochem       Date:  2015-05-03       Impact factor: 4.059

Review 8.  Plant Carbonic Anhydrases: Structures, Locations, Evolution, and Physiological Roles.

Authors:  Robert J DiMario; Harmony Clayton; Ananya Mukherjee; Martha Ludwig; James V Moroney
Journal:  Mol Plant       Date:  2016-09-16       Impact factor: 13.164

Review 9.  An Update on the Metabolic Roles of Carbonic Anhydrases in the Model Alga Chlamydomonas reinhardtii.

Authors:  Ashok Aspatwar; Susanna Haapanen; Seppo Parkkila
Journal:  Metabolites       Date:  2018-03-13

10.  Dioxygen, an unexpected carbonic anhydrase ligand.

Authors:  Marta Ferraroni; Roberto Gaspari; Andrea Scozzafava; Andrea Cavalli; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.